Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the
coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including …

Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the
composition and mechanism of action are not fully known. Therefore, we undertook a two …

According to statistics by John Hopkins University (JHU) of Medicine, SARS-CoV-2
viruseinduced coronavirus disease 2019 (COVID-19) has, to date (April 22, 2020), infected …

Introduction The coronavirus disease 2019 (COVID-19) pandemic has spread globally.
Therapeutic options including antivirals, anti-inflammatory compounds, and vaccines are still …

Convalescent plasma is a suggested treatment for Coronavirus disease 2019 (Covid-19),
but its efficacy is uncertain. We aimed to evaluate whether the use of convalescent plasma is …

Convalescent plasma (CP) transfusion has been indicated as a promising therapy in the
treatment for other emerging viral infections. However, the quality control of CP and …

The pandemic COVID-19 has spread widely throughout the globe and has been responsible
for millions of deaths worldwide. Recently, it has been identified that there is no specific and …

Introduction Passive antibody therapy has been used to immunize vulnerable people
against infectious agents. In this study, we aim to investigate the efficacy of convalescent …

Various agents are currently under evaluation as potential treatments in the fight against
coronavirus disease 2019 (COVID-19). Plasma from patients that have overcome COVID-19 …

Convalescent plasma can provide passive immunity during viral outbreaks, but the benefit is
uncertain for the treatment of novel coronavirus disease 2019 (COVID‐19). Our goal is to …